Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Dexmedetomidine. [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating the pharmacokinetics and pharmacodynamics of oral transmucosal dexmedetomidine for sedation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sedation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Assiut University | Conditions: Sedation | Phase 2, Phase 3 | Status: COMPLETED